gliclazide has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalani, K; Khan, F; Pant, AB; Singh, AK; Srivastava, SK; Yadav, DK | 1 |
| Cai, J; Guan, C; Wang, P; Wang, W; Zhao, K | 1 |
2 other study(ies) available for gliclazide and Breast Neoplasms
| Article | Year |
|---|---|
Design, synthesis and in vitro evaluation of 18β-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Drug Design; Glycyrrhetinic Acid; Humans; MCF-7 Cells; Models, Molecular; Quantitative Structure-Activity Relationship | 2014 |
Inhibition of gap junction channel attenuates the migration of breast cancer cells.
Topics: Actin Cytoskeleton; Analysis of Variance; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Female; Gap Junctions; Glycyrrhetinic Acid; Humans; Indoles; Neoplasm Invasiveness; Neoplasm Metastasis; Octanols | 2012 |